Skip to main content
DNA Labs India

CEP57 Gene Mosaic variegated aneuploidy syndrome type 2 NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

CEP57 Gene Mosaic variegated aneuploidy syndrome type 2 NGS Genetic Test

Short Name: CEP57 NGS Test

Also known as: CEP57 Gene Mutation Test, MVA2 Genetic Test, CEP57 NGS Analysis

CEP57 Gene Mosaic variegated aneuploidy syndrome type 2 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Reports are typically delivered within 3 to 4 weeks after sample receipt.. Free home collection in 300+ cities across India.

NGS Genetic Test🏠 Home Collection

🩺 Medically Reviewed By

Overview

The primary purpose of this test is to confirm a clinical suspicion of Mosaic Variegated Aneuploidy Syndrome Type 2 by identifying mutations in the CEP57 gene. It also aids in carrier testing for at-risk family members, prenatal diagnosis in affected families, and providing prognostic information for early intervention and cancer surveillance.

Test Code
5857
CPT Code
81407
ICD Code
Q99.8
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
Reports are typically delivered within 3 to 4 weeks after sample receipt.
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

No special preparation required. However, a genetic counseling session is recommended prior to testing to discuss implications.

Method: Venipuncture or Finger-prick

Step 2

Laboratory Analysis

A blood sample is drawn by a trained phlebotomist. For FTA card, a simple finger-prick is sufficient.

Step 3

Report Delivery

No restrictions. Patient can resume normal activities immediately.

Timeline: Reports are typically delivered within 3 to 4 weeks after sample receipt.

Patient Instructions

1
Before the Test:No special preparation. Genetic counseling is advised.
2
During the Test:Simple blood draw or FTA card sample collection.
3
After the Test:No restrictions. Await results in 3-4 weeks.

About This Test

Who Should Get This Test

The primary purpose of this test is to confirm a clinical suspicion of Mosaic Variegated Aneuploidy Syndrome Type 2 by identifying mutations in the CEP57 gene. It also aids in carrier testing for at-risk family members, prenatal diagnosis in affected families, and providing prognostic information for early intervention and cancer surveillance.

How to Prepare

  • Ensure patient identity verification
  • Use sterile EDTA vacutainer for blood
  • If using FTA card, allow blood to dry completely
  • Label sample with patient name and date
  • Transport at ambient temperature

Doctor's Notes

Reviewed by — MBBS, MD (Pathology) · Reg. No. 21521

"CEP57 mutations are rare but should be considered in patients with unexplained aneuploidy, growth retardation, and microcephaly. Early genetic diagnosis enables appropriate surveillance for malignancies and developmental support."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample Volume2-3 ml blood or 1 drop on FTA card
ContainerEDTA vacutainer or FTA card
Collection MethodVenipuncture or Finger-prick

Sample Stability

Blood in EDTA
Extracted DNA
FTA card
Sample Rejection Criteria:
  • Hemolyzed blood sample
  • Clotted blood sample
  • Insufficient sample volume
  • Improper labeling
  • Sample received after prolonged transit without proper storage

Understanding Your Results

The test report will indicate whether a pathogenic variant in the CEP57 gene was identified. If positive, the specific variant and its clinical significance will be described. If negative, it does not completely rule out MVA2, especially if mosaicism is low.
📊

Positive (Pathogenic variant)

Confirms diagnosis of MVA2. Genetic counseling recommended for family members.

📊

Negative (No variant)

No mutation detected in CEP57. Consider other genetic causes if clinical suspicion remains.

📊

Variant of Uncertain Significance (VUS)

Further testing of family members may help classify the variant.

⚠️ When to Consult a Doctor:

If you or your child have symptoms such as growth delay, microcephaly, intellectual disability, or a family history of MVA2, consult a clinical geneticist for evaluation and testing.

Limitations

  • NGS may not detect deep intronic variants or large structural rearrangements
  • Mosaic variants with low allele frequency may be missed
  • Variant of uncertain significance (VUS) may require further family studies
  • Test does not assess other genes associated with aneuploidy syndromes

Risks & Considerations

  • Minimal risk of bruising at venipuncture site
  • No significant health risks associated with the test

Interfering Factors

  • Contamination of sample with maternal cells (if prenatal)
  • Low DNA quality or quantity
  • Mosaicism may be below detection limit of NGS
  • Presence of large deletions/duplications not detected by standard NGS

Compare With Similar Tests

TestCEP57 Gene Mosaic variegated aneuploidy syndrome type 2 NGS Genetic TestChromosomal Microarray (CMA)KaryotypeWhole Exome Sequencing (WES)
ComparisonCEP57 Gene Mosaic variegated aneuploidy syndrome type 2 NGS Genetic Test

Frequently Asked Questions

What is Mosaic Variegated Aneuploidy Syndrome Type 2?
MVA2 is a rare genetic disorder caused by mutations in the CEP57 gene, leading to abnormal chromosome numbers in cells, resulting in growth problems, intellectual disability, and increased cancer risk.
How is the CEP57 gene test performed?
The test uses Next-Generation Sequencing (NGS) on a blood or saliva sample to detect mutations in the CEP57 gene.
What is the cost of the CEP57 NGS test?
The cost is INR 20,000 at DNA Labs India, with free home sample collection available.
Is fasting required before the test?
No, fasting is not required for this genetic test.
How long does it take to get results?
Results are typically available within 3 to 4 weeks after the sample is received.
Can this test detect all types of CEP57 mutations?
NGS detects most point mutations and small indels, but may miss large deletions or deep intronic variants.
Who should consider this test?
Individuals with symptoms suggestive of MVA2, or those with a family history of the condition, should consider testing.
Is genetic counseling included?
Yes, a genetic counseling session is included to discuss the implications of the test and results.
What sample types are accepted?
Blood, extracted DNA, or one drop of blood on an FTA card are accepted.
Is the test available across India?
Yes, home sample collection is available in over 200 cities across India.
What does a positive result mean?
A positive result confirms the presence of a pathogenic CEP57 mutation, indicating a diagnosis of MVA2.
Are there any risks associated with the test?
The test is non-invasive with minimal risks, such as slight bruising at the blood draw site.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.